市净率比较市场价值与账面价值。较低的市净率可能代表价值机会。
共 181 家公司有市净率数据。
先确认商业模式、利润率、资本结构和当前估值倍数，避免只看单一排名就下结论。
倍数看起来便宜，不代表折现率合理。先验证资本成本，再决定 DCF 假设。
用同一家公司对应的 DCF 页面验证合理价值区间，避免排名、倍数和现金流假设互相脱节。
数据每日更新 · 来源: SEC EDGAR, Polygon.io
| PMCB |
| $7M |
| 0.1 |
| 3 | NAII | $17M | 0.2 |
| 4 | AVD | $75M | 0.3 |
| 5 | VHI | $399M | 0.4 |
| 6 | VIVS | $4M | 0.4 |
| 7 | FMC | $2.2B | 0.5 |
| 8 | FATE | $156M | 0.5 |
| 9 | TLRY | $805M | 0.5 |
| 10 | COTY | $2.0B | 0.6 |
| 11 | TOVX | $11M | 0.6 |
| 12 | GOVX | $3M | 0.6 |
| 13 | CDIO | $6M | 0.6 |
| 14 | QDEL | $1.2B | 0.6 |
| 15 | AMRN | $305M | 0.6 |
| 16 | USNA | $342M | 0.6 |
| 17 | OPK | $888M | 0.7 |
| 18 | MYGN | $459M | 0.7 |
| 19 | EPC | $1.0B | 0.7 |
| 20 | NL | $287M | 0.7 |
| 21 | AIMD | $12M | 0.8 |
| 22 | SCYX | $46M | 0.8 |
| 23 | TXMD | $24M | 0.9 |
| 24 | KRO | $748M | 0.9 |
| 25 | CRON | $974M | 0.9 |
| 26 | CRVO | $37M | 1.0 |
| 27 | SCL | $1.2B | 1.0 |
| 28 | NEOG | $2.1B | 1.0 |
| 29 | ORMP | $154M | 1.1 |
| 30 | ABOS | $194M | 1.1 |
| 31 | MTEX | $9M | 1.1 |
| 32 | RMTI | $37M | 1.1 |
| 33 | ATYR | $82M | 1.2 |
| 34 | CYRX | $496M | 1.2 |
| 35 | MTX | $2.3B | 1.3 |
| 36 | MNOV | $69M | 1.3 |
| 37 | INO | $91M | 1.3 |
| 38 | CELZ | $8M | 1.3 |
| 39 | NEUP | $25M | 1.3 |
| 40 | IFF | $18.5B | 1.3 |
| 41 | CRDF | $111M | 1.3 |
| 42 | ACNT | $127M | 1.4 |
| 43 | LSTA | $41M | 1.4 |
| 44 | IOSP | $1.9B | 1.4 |
| 45 | EMN | $8.4B | 1.4 |
| 46 | MRKR | $27M | 1.4 |
| 47 | BIIB | $26.3B | 1.4 |
| 48 | AVNT | $3.5B | 1.5 |
| 49 | SIGA | $328M | 1.5 |
| 50 | SRPT | $2.3B | 1.5 |
| 51 | LFVN | $53M | 1.5 |
| 52 | BMRA | $6M | 1.5 |
| 53 | LXFR | $354M | 1.6 |
| 54 | TARA | $277M | 1.7 |
| 55 | CATX | $484M | 1.7 |
| 56 | ALTO | $376M | 1.7 |
| 57 | FUL | $3.4B | 1.7 |
| 58 | OLN | $3.2B | 1.7 |
| 59 | PFE | $154.2B | 1.7 |
| 60 | FSI | $67M | 1.8 |
| 61 | ROG | $2.1B | 1.8 |
| 62 | RXRX | $1.9B | 1.8 |
| 63 | BMRN | $10.7B | 1.9 |
| 64 | MGNX | $222M | 1.9 |
| 65 | TKNO | $162M | 2.0 |
| 66 | NTLA | $1.7B | 2.0 |
| 67 | LXU | $994M | 2.0 |
| 68 | CPIX | $48M | 2.1 |
| 69 | IOVA | $1.5B | 2.1 |
| 70 | VERU | $39M | 2.1 |
| 71 | ENVB | $4M | 2.3 |
| 72 | CVM | $37M | 2.3 |
| 73 | ALB | $22.4B | 2.3 |
| 74 | FTLF | $87M | 2.4 |
| 75 | LITS | $42M | 2.5 |
| 76 | CBT | $3.9B | 2.5 |
| 77 | UG | $30M | 2.5 |
| 78 | REX | $1.4B | 2.5 |
| 79 | ICCC | $70M | 2.5 |
| 80 | REGN | $79.9B | 2.6 |
| 81 | INVA | $1.8B | 2.6 |
| 82 | TENX | $254M | 2.8 |
| 83 | IMNN | $12M | 2.9 |
| 84 | SNGX | $12M | 2.9 |
| 85 | TOMZ | $12M | 2.9 |
| 86 | NATR | $469M | 2.9 |
| 87 | QCLS | $29M | 3.0 |
| 88 | AURA | $455M | 3.0 |
| 89 | JAZZ | $12.4B | 3.0 |
| 90 | AVXL | $289M | 3.0 |
| 91 | PPG | $24.7B | 3.1 |
| 92 | CDXS | $215M | 3.2 |
| 93 | CPHI | $25M | 3.2 |
| 94 | DTIL | $187M | 3.3 |
| 95 | SXT | $4.0B | 3.3 |
| 96 | ABT | $175.6B | 3.4 |
| 97 | TCRT | $7M | 3.4 |
| 98 | ERNA | $6M | 3.5 |
| 99 | CLDX | $2.6B | 3.5 |
| 100 | RGEN | $7.4B | 3.7 |